These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Validation of a CE assay for the analysis of isomeric aminopyridines and diaminopyridines. Sabbah S; Scriba GK J Pharm Biomed Anal; 2001 Feb; 24(4):695-703. PubMed ID: 11272328 [TBL] [Abstract][Full Text] [Related]
9. Liquid-chromatographic determination of 4-aminopyridine in serum, saliva, and urine. Uges DR; Bouma P Clin Chem; 1981 Mar; 27(3):437-40. PubMed ID: 7471395 [TBL] [Abstract][Full Text] [Related]
10. The effect of some new aminopyridines on mammalian non-myelinated nerve fibres. Den Hertog A; Pielkenrood J; Biessels P; Agoston S Eur J Pharmacol; 1983 Oct; 94(3-4):353-5. PubMed ID: 6653665 [TBL] [Abstract][Full Text] [Related]
11. Synaptosomal calcium metabolism during hypoxia and 3,4-diaminopyridine treatment. Peterson C; Gibson GE J Neurochem; 1984 Jan; 42(1):248-53. PubMed ID: 6689690 [TBL] [Abstract][Full Text] [Related]
12. Amelioration of age-related neurochemical and behavioral deficits by 3,4-diaminopyridine. Peterson C; Gibson GE Neurobiol Aging; 1983; 4(1):25-30. PubMed ID: 6877484 [TBL] [Abstract][Full Text] [Related]
13. A comparison of 3,4-diaminopyridine and 4-aminopyridine in the anaesthetized cat. Durant NN; Nguyen N; Lee C; Katz RL Eur J Pharmacol; 1982 Oct; 84(3-4):215-9. PubMed ID: 6293848 [TBL] [Abstract][Full Text] [Related]
14. Ineffectiveness of 3,4-diaminopyridine as a therapy for type C botulism. Siegel LS; Price JI Toxicon; 1987; 25(9):1015-8. PubMed ID: 3433299 [TBL] [Abstract][Full Text] [Related]
15. Ion-pair high-performance liquid chromatographic assay of 4-aminopyridine in serum. Shinohara Y; Miller RD; Castagnoli N J Chromatogr; 1982 Jul; 230(2):363-72. PubMed ID: 7107782 [TBL] [Abstract][Full Text] [Related]
16. Sensitive trace-first liquid chromatographic determination of 4-aminopyridine in 3,4-diaminopyridine. Perry JA; Chang M J Pharm Sci; 1990 May; 79(5):437-9. PubMed ID: 2352165 [TBL] [Abstract][Full Text] [Related]
17. Comparison of some pharmacological properties of 4-aminopyridine and 3,4-diaminopyridine in vivo. Houston T; Pleuvry BJ Br J Anaesth; 1984 Oct; 56(10):1139-42. PubMed ID: 6148094 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of a capillary electrophoresis assay for the determination of 3,4-diaminopyridine and 4-aminopyridine including related substances. Sabbah S; Scriba GK J Chromatogr A; 2001 Jan; 907(1-2):321-8. PubMed ID: 11217039 [TBL] [Abstract][Full Text] [Related]
19. 4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis. Polman CH; Bertelsmann FW; de Waal R; van Diemen HA; Uitdehaag BM; van Loenen AC; Koetsier JC Arch Neurol; 1994 Nov; 51(11):1136-9. PubMed ID: 7980110 [TBL] [Abstract][Full Text] [Related]
20. Ultrasound driven synthesis of reversed-phase stationary phases for liquid chromatography using 4-dimethyl-aminopyridine as acid-acceptor. Sentell KB; Barnes KW; Dorsey JG J Chromatogr; 1988 Nov; 455():95-104. PubMed ID: 3235626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]